Oxygenta Pharmaceutical Ltd

NSE: SSORGS · BSE: 524636 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹48.17
Market cap: ₹178.2 Cr
Revenue (annual): ₹113.0 Cr
Net profit (annual): ₹-17.57 Cr
P/E (TTM): -13.1×Sector 47.4×
Promoter holding: 56.54%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Board Meeting Date 2 Annual General Meeting 2 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

27 Jul 2026 18:06 IST BSE

Financial Results

Oxygenta Pharmaceutical Q1 FY27 Results: Net Loss of ₹2.1 Cr, Loss Narrows

Oxygenta Pharmaceutical Ltd reported revenue from operations of ₹37 Cr (+145.0% YoY) and a net loss of ₹2.1 Cr for Q1 FY27.

Key figure: Net loss ₹2.1 Cr

Open full results → Read the filing ↗

23 May 2026 17:36 IST BSE

Financial Results

Oxygenta Pharmaceutical Q4 FY26 Results: Net Loss of ₹1.7 Cr, Loss Narrows

Oxygenta Pharmaceutical Ltd reported revenue from operations of ₹49.6 Cr (+0.2% YoY) and a net loss of ₹1.7 Cr for Q4 FY26.

Key figure: Net loss ₹1.7 Cr

Open full results → Read the filing ↗

23 May 2026 17:35 IST BSE

Financial Results

Oxygenta Pharmaceutical Financial Results

Oxygenta Pharmaceutical Limited reported its audited financial results for the year ended March 31, 2026. The company also announced key board appointments and auditor changes.

Read the filing ↗